Cargando…
Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages
PURPOSE: Monocytes serve as sanctuary sites for HIV-1 from which virus is difficult to be eliminated. Therefore, an effective viral suppression in monocytes is critical for effective antiretroviral therapy (ART). This study focuses on a new strategy using nanoformulation to optimize the efficacy of...
Autores principales: | Gong, Yuqing, Chowdhury, Pallabita, Midde, Narasimha M., Rahman, Mohammad A., Yallapu, Murali M., Kumar, Santosh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704044/ https://www.ncbi.nlm.nih.gov/pubmed/29214223 http://dx.doi.org/10.1016/j.bbrep.2017.10.005 |
Ejemplares similares
-
Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages
por: Gong, Yuqing, et al.
Publicado: (2020) -
An Elvitegravir Nanoformulation Crosses the Blood–Brain Barrier and Suppresses HIV-1 Replication in Microglia
por: Gong, Yuqing, et al.
Publicado: (2020) -
Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method
por: Midde, Narasimha M., et al.
Publicado: (2016) -
Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells
por: Midde, Narasimha M., et al.
Publicado: (2017) -
miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
por: Nagesh, Prashanth K. B., et al.
Publicado: (2018)